OTCBlaze Newsletter
October 5, 2010
Hi everyone,
OUR NEW BLAZIN TRADE ALERT is A5 LABORATORIES INC. (
AFLB.OB), WHICH CLOSED AT .72 YESTERDAY AND IS CURRENTLY AT .74!!
We expect
AFLB to have a very positive week, as we understand there is much exposure forthcoming, starting now. The timing of our alert couldn`t be better! Here`s why:
Take a look at the annotated chart below. What you`ll see is two previous runs after
AFLB hit the .65 support level. After it hit that level (two different times), it went up to $1.00 and over, which is about 40% from here. Well,
AFLB just hit that support level yesterday!!! Getting in at or near support is the way to go!! We also like the fact that the 1st resistance level is 12% higher than yesterday`s close and the next one is 22% higher! This one could be a nice 1-3 day swing trade or day trading this one will likely work out well too!
AFLB is a pretty liquid stock, which makes day trading it much easier.
AFLB is getting into a really interesting business and you will find out a lot more about A5 Labs below...
Pinksheets Level:
OTCQB Pinksheets Link: http://www.otcmarkets.com/stock/
AFLB/company-info
Support Levels: .65 and .58
Resistance Levels: .80 and .88
Stock Chart: http://stockcharts.com/h-sc/uis=
AFLB&p=D&b=5&g=0&id=p22528908701&a0162641
Company Website: http://www.a5labs.com/
Yahoo Finance Link: http://finance.yahoo.com/qs=
AFLB.OB
About A5 Labs:
A5 Laboratories provides contract analytical, regulatory and product development services to the Pharmaceutical industry. With a dedicated commitment to its client`s needs, A5 Laboratories offers a full range of services to the pharmaceutical industry in variety of fields, all in compliance with Good Laboratory Practices and current Good Manufacturing Practices regulations.
The company has recently reported an acquisition of an Interferon business, which could be huge!! http://www.otcmarkets.com/edgar/GetFilingHtmlFilingID51375
What is an Interferon
Interferon (IFN) is a type of protein called a cytokine that is secreted by cells of the body during an infection. It can inhibit viruses from spreading to neighboring cells and it can aid in destroying cancerous cells. Interferon therapy takes advantage of these natural protective properties. Commercial interferon is used as a treatment for viral infections, such as hepatitis C, and as a treatment for certain cancers.
What does it do
Interferon-alpha has many effects on the cells in the body. When a virus has infected cells in a tissue or organ, interferon protects neighboring uninfected cells and halts the spread of the virus. Interferon therapy stimulates the release of enzymes that interfere with protein synthesis and thereby destroys virus-infected cells. Generally, interferon-alpha is one choice of treatment for patients infected with hepatitis C. It can be used in combination with other medications, such as the antiviral drug ribavirin, to improve the response to hepatitis C.
Another effect of IFN-alpha is to boost the immune system to fight off the spread of cancer in the body. Different cell types in the body, namely natural killer cells (NK cells) or macrophages, are activated by interferon and can then attack and destroy cancer cells. Interferon also increases expression of proteins on the surface of tumor cells, thereby making them more visible for attack by cells of the immune system.
Interferon therapy is used to treat patients suffering from malignant melanoma that has spread to lymph nodes. It has been shown to reduce the rate of recurrence in patients with melanoma. Interferon can also be used to treat other cancers, mainly leukemia and lymphoma.
Good luck trading today!!
OTCBlaze
Read Disclaimer:
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, joining our e-mail list, or viewing our posts on Twitter. PLEASE NOTE: Stock Promotion Group LLC ) employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.otcblaze.com/index.phpoption=com_content&view=article&id&Itemid Release of Liability: Through use of our website/newsletter/Twiitter posts, you agree to hold OTCBlaze.com , its operators owners and employees harmless and to compeltely release them from any and all liability due to any and all loss and/or its affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCBlaze.com encourages readers and investors to supplement the information in these reports with independent research and other pro advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCBlaze.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. OTCBlaze.com often receives compensation for marketing, awareness and investor relation services, which can be viewed within our disclaimer. Stock Promotion Group, LLC , nor any of its affiliates are not registered investment advisors or a broker dealers.
Follow Us on Twitter
http://twitter.com/otcblaze
Next Big Pick
October 5, 2010 @ 10:00 a.m.!
(C) 2010 OTCBlaze
This email was sent by OTCBlaze, 2711 Centerville Road, Wilmington, DE 19808, using Express Email Marketing. You subscribed to this permission-based list on 12/29/2009.
Express Email Marketing supports permission-based email marketing. You can change your preferences (http://app.expressemailmarketing.com/survey.aspxid958&sid3873381&campaignId3130&SFID850) or
